LIVIVO - Search results -

Search results

Result 1 - 10 of total 24

Search options

Article ; Online: Oxyhydroxyde sucroferrique, un nouveau chélateur des phosphates à base de fer. Quelle utilisation chez le patient dialysé ?

Bataille, Pierre / Delattre, Vincent / Daroux, Maité

2017 Volume 13 Suppl 1, Page(s) S103–S108

Abstract: International guidelines suggest lowering elevated phosphorus level to the normal range in patients on dialysis. Among the phosphate-lowering strategies, phosphate binder is frequently used in addition to dietary phosphate restriction and an adequate ... ...

Title translation	Sucroferric oxyhydroxide, a novel iron-based phosphate binder. Which current use in dialysis patients?
Abstract	International guidelines suggest lowering elevated phosphorus level to the normal range in patients on dialysis. Among the phosphate-lowering strategies, phosphate binder is frequently used in addition to dietary phosphate restriction and an adequate dialysis strategy. However, serum phosphate concentration higher than 1.78mmol/L is observed in more than 40% of patients justifying the quest for new drugs. Sucroferric oxyhydroxide is one of the new iron-based agents and is available in France since May 2016. A recent international multicentre study showed this new drug to be as efficacious and non-inferior to sevelamer carbonate in magnitude of serum phosphate control. The serum phosphorus-lowering effect was maintained over 1year. When compared to carbonate sevelamer, the pill-burden was half with sucroferric oxyhydroxide because of its high phosphate binding capacity. As previously shown by experimental studies, no risk of iron accumulation was observed since iron absorption is negligible. Discolored feces and diarrhea were fairly frequent side effects. When diarrhea subsides, the tolerability of this new phosphate binder is excellent on a long-term basis.
Language	French
Publishing date	2017-04
Publishing country	France
Document type	English Abstract ; Journal Article
ZDB-ID	2229575-6
ISSN	1872-9177 ; 1769-7255
ISSN (online)	1872-9177
ISSN	1769-7255
DOI	10.1016/j.nephro.2017.01.004
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6298: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Manual fish length measurement accuracy for adult river fish using an acoustic camera (DIDSON).

Daroux, Aurélie / Martignac, François / Nevoux, Marie / Baglinière, Jean L / Ombredane, Dominique / Guillard, Jean

Journal of fish biology

2019 Volume 95, Issue 2, Page(s) 480–489

Abstract: Total lengths ( ... ...

Abstract	Total lengths (L
MeSH term(s)	Animals ; Carps/anatomy & histology ; Ecology/methods ; Oncorhynchus mykiss/anatomy & histology ; Reproducibility of Results ; Rivers ; Sound ; Swimming ; Video Recording/instrumentation
Language	English
Publishing date	2019-06-21
Publishing country	England
Document type	Journal Article
ZDB-ID	410564-3
ISSN	1095-8649 ; 0022-1112
ISSN (online)	1095-8649
ISSN	0022-1112
DOI	10.1111/jfb.13996
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Bonn / Germany

Z 4814: Show issues
Z 4814 a: Show issues

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease.

Caillard, Pauline / Vigneau, Cécile / Halimi, Jean-Michel / Hazzan, Marc / Thervet, Eric / Heitz, Morgane / Juillard, Laurent / Audard, Vincent / Rabant, Marion / Hertig, Alexandre / Subra, Jean-François / Vuiblet, Vincent / Guerrot, Dominique / Tamain, Mathilde / Essig, Marie / Lobbedez, Thierry / Quemeneur, Thomas / Legendre, Mathieu / Ganea, Alexandre /

Peraldi, Marie-Noëlle / Vrtovsnik, François / Daroux, Maïté / Makdassi, Raïfah / Choukroun, Gabriel / Titeca-Beauport, Dimitri

Frontiers in immunology

2023 Volume 14, Page(s) 1190394

Abstract: Background and objectives: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective ...

Abstract	Background and objectives: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective of this study was to analyze the prognostic value of the serum C3 level and the presence of C3 glomerular deposits in patients with anti-GBM disease. Methods: We conducted a retrospective cohort study of 150 single-positive patients with anti-GBM disease diagnosed between 1997 and 2017. Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C3≥1.23 g/L) groups) and positivity for C3 glomerular staining (forming the C3+ and C3- groups). The main outcomes were kidney survival and patient survival. Results: Of the 150 patients included, 89 (65%) were men. The median [interquartile range (IQR)] age was 45 [26-64]. At diagnosis, kidney involvement was characterized by a median [IQR] peak serum creatinine (SCr) level of 578 [298-977] µmol/L, and 106 (71%) patients required dialysis. Patients in the low C3 group (72 patients) had more severe kidney disease at presentation, as characterized by higher prevalences of oligoanuria, peak SCr ≥500 µmol/L (69%, vs. 53% in the high C3 group; p=0.03), nephrotic syndrome (42%, vs. 24%, respectively; p=0.02) and fibrous forms on the kidney biopsy (21%, vs. 8%, respectively; p=0.04). Similarly, we observed a negative association between the presence of C3 glomerular deposits (in 52 (41%) patients) and the prevalence of cellular forms (83%, vs. 58% in the C3- group; p=0.003) and acute tubulo-interstitial lesions (60%, vs. 36% in the C3- group; p=0.007). When considering patients not on dialysis at diagnosis, the kidney survival rate at 12 months was poorer in the C3+ group (50% [25-76], vs. 91% [78-100] in the C3- group; p=0.01), with a hazard ratio [95% confidence interval] of 5.71 [1.13-28.85] (p=0.04, after adjusting for SCr). Conclusion: In patients with anti-GBM disease, a low serum C3 level and the presence of C3 glomerular deposits were associated with more severe disease and histological kidney involvement at diagnosis. In patients not on dialysis at diagnosis, the presence of C3 deposits was associated with worse kidney survival.
MeSH term(s)	Male ; Humans ; Female ; Anti-Glomerular Basement Membrane Disease/complications ; Prognosis ; Complement C3/analysis ; Retrospective Studies ; Kidney/pathology
Chemical Substances	Complement C3
Language	English
Publishing date	2023-07-05
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2023.1190394
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Kidney, heart and brain: three organs targeted by ageing and glycation.

Frimat, Marie / Daroux, Maité / Litke, Rachel / Nevière, Rémi / Tessier, Frédéric J / Boulanger, Eric

Clinical science (London, England : 1979)

2017 Volume 131, Issue 11, Page(s) 1069–1092

Abstract: Advanced glycation end-product (AGE) is the generic term for a heterogeneous group of derivatives arising from a non-enzymatic reaction between reducing sugars and proteins. In recent years, evidence has accumulated that incriminates AGEs in pathogenic ... ...

Abstract	Advanced glycation end-product (AGE) is the generic term for a heterogeneous group of derivatives arising from a non-enzymatic reaction between reducing sugars and proteins. In recent years, evidence has accumulated that incriminates AGEs in pathogenic processes associated with both chronic hyperglycaemia and age-related diseases. Regardless of their exogenous or endogenous origin, the accumulation of AGEs and their derivatives could promote accelerated ageing by leading to protein modifications and activating several inflammatory signalling pathways via AGE-specific receptors. However, it remains to be demonstrated whether preventing the accumulation of AGEs and their effects is an important therapeutic option for successful ageing. The present review gives an overview of the current knowledge on the pathogenic role of AGEs by focusing on three AGE target organs: kidney, heart and brain. For each of these organs we concentrate on an age-related disease, each of which is a major public health issue: chronic kidney disease, heart dysfunction and neurodegenerative diseases. Even though strong connections have been highlighted between glycation and age-related pathogenesis, causal links still need to be validated. In each case, we report evidence and uncertainties suggested by animal or epidemiological studies on the possible link between pathogenesis and glycation in a chronic hyperglycaemic state, in the absence of diabetes, and with exogenous AGEs alone. Finally, we present some promising anti-AGE strategies that are currently being studied.
MeSH term(s)	Aging/metabolism ; Diet ; Glycation End Products, Advanced/metabolism ; Glycosylation ; Heart Diseases/metabolism ; Heart Diseases/prevention & control ; Humans ; Molecular Targeted Therapy/methods ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/prevention & control ; Receptor for Advanced Glycation End Products/antagonists & inhibitors ; Renal Insufficiency, Chronic/metabolism ; Renal Insufficiency, Chronic/prevention & control
Chemical Substances	AGER protein, human ; Glycation End Products, Advanced ; Receptor for Advanced Glycation End Products
Language	English
Publishing date	2017-06-01
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	206835-7
ISSN	1470-8736 ; 0301-0538 ; 0009-0360 ; 0143-5221
ISSN (online)	1470-8736
ISSN	0301-0538 ; 0009-0360 ; 0143-5221
DOI	10.1042/CS20160823
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.220: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Peritoneal aging during PD: implication of RAGE, the receptor for AGEs.

Boulanger, E / Daroux, M

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

2008 Volume 28 Suppl 6, Page(s) 5–10

Abstract: During last years, the number of patients who have been continuously treated by peritoneal dialysis (PD) for over 5 or 10 years has markedly increased. Sclerosing syndromes and membrane failure are the most common complications that are now currently ... ...

Abstract	During last years, the number of patients who have been continuously treated by peritoneal dialysis (PD) for over 5 or 10 years has markedly increased. Sclerosing syndromes and membrane failure are the most common complications that are now currently observed in long-term PD patients. Exposure to conventional PD fluids (PDFs) with poor biocompatibility induces a kind of <<chemical peritonitis>> in response of bad <<biotolerance>>. Theperitoneal fibroblasts, mesothelial cells and especially endothelial cells function as a filtration barrier, but also control intraperitoneal inflammation as well as leukocytes and macrophages.Peritoneal exposure to conventional poorly biocompatible PDFs which combine non-physiological pH, high glucose concentrations,and high levels of glucose degradation products (GDPs), is associated with an accelerated peritoneal aging. Heat sterilization of PDFs induces the formation of GDPs which are involved in the formation of advanced glycation end-products (AGEs).Glucose, GDPs and AGEs participate to the peritoneal membrane failure and aging. AGEs via RAGE (receptor for AGEs) are involved in human peritoneal mesothelial cell (HPMC) activation.In the present work, we summarize our previous in vitro works regarding mesothelial RAGE implication in the peritoneal membrane aging. Two periods of aging are distinguished: i) early peritoneal changes related to mesothelial cell activation and loss, ii)late membrane alteration correlated to submesothelial fibrosis and neovascularization.
MeSH term(s)	Aging ; Animals ; Humans ; Peritoneum/pathology ; Peritoneum/physiopathology ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic/physiology ; Time Factors
Chemical Substances	Receptor for Advanced Glycation End Products ; Receptors, Immunologic
Language	English
Publishing date	2008
Publishing country	Spain
Document type	Journal Article
ZDB-ID	632512-9
ISSN	1989-2284 ; 0211-6995
ISSN (online)	1989-2284
ISSN	0211-6995
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 2773: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 56: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Differential Determinants of Tubular Phosphate Reabsorption: Insights on Renal Excretion of Phosphates in Kidney Disease.

Tabibzadeh, Nahid / Mentaverri, Romuald / Daroux, Maïté / Mesbah, Rafik / Delpierre, Alexia / Paul, Jean-Gabriel / Deken, Valérie / Massy, Ziad A / Bataille, Pierre

American journal of nephrology

2018 Volume 47, Issue 5, Page(s) 300–303

Abstract: We assessed the tubular reabsorption of phosphate (TRP) and maximal renal threshold for phosphate reabsorption to glomerular filtration rate (TmPi/GFR) and their determinants in 64 stages 2-4 chronic kidney disease (CKD) patients in order to define the ... ...

Abstract	We assessed the tubular reabsorption of phosphate (TRP) and maximal renal threshold for phosphate reabsorption to glomerular filtration rate (TmPi/GFR) and their determinants in 64 stages 2-4 chronic kidney disease (CKD) patients in order to define the early changes in phosphate metabolism in CKD. In multivariable analysis, TmPi/GFR correlates were estimated GFR (eGFR), intact parathyroid hormone (iPTH), and hemoglobin (R2 = 0.417), while TRP correlates were eGFR, iPTH, 24-h phosphaturia, and calcitriol (R2 = 0.72). This suggests that TmPi/GFR and TRP, respectively, assess hemoglobin-phosphate and bowel-kidney phosphate regulation axis. Iron supplementation based on TmPi/GFR or earlier phosphate restriction based on TRP should be investigated in view of modifying clinical outcomes in CKD.
MeSH term(s)	Aged ; Cross-Sectional Studies ; Female ; Glomerular Filtration Rate ; Hemoglobins/analysis ; Humans ; Kidney Tubules/physiopathology ; Male ; Middle Aged ; Parathyroid Hormone/blood ; Parathyroid Hormone/urine ; Phosphates/blood ; Phosphates/metabolism ; Phosphates/urine ; Prospective Studies ; Renal Elimination/physiology ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/physiopathology ; Renal Insufficiency, Chronic/urine ; Renal Reabsorption/physiology
Chemical Substances	Hemoglobins ; Parathyroid Hormone ; Phosphates
Language	English
Publishing date	2018-05-18
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	604540-6
ISSN	1421-9670 ; 0250-8095
ISSN (online)	1421-9670
ISSN	0250-8095
DOI	10.1159/000488864
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1635: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Early Renal Recovery after the First Flare of Pauci-Immune Glomerulonephritis.

American journal of nephrology

2022 Volume 53, Issue 1, Page(s) 59–68

Abstract: Introduction: Renal involvement is a severe manifestation of antineutrophil cytoplasmic antibody-associated vasculitis. Patients often progress to end-stage renal disease. The potential for renal recovery after the first flare has seldom been studied. ... ...

Abstract	Introduction: Renal involvement is a severe manifestation of antineutrophil cytoplasmic antibody-associated vasculitis. Patients often progress to end-stage renal disease. The potential for renal recovery after the first flare has seldom been studied. Our objectives were to describe the evolution of the estimated glomerular filtration rate (eGFR) and identify factors associated with the change in the eGFR between diagnosis and the follow-up at 3 months (ΔeGFRM0-M3). Methods: This was a retrospective study over the period 2003-2018 of incident patients in the Nord-Pas-de-Calais (France). The primary outcome was the ΔeGFRM0-M3. Results: One hundred and seventy-seven patients were included. The eGFR at 3 months was significantly higher than at diagnosis (mean ± standard deviation, 40 ± 24 vs. 28 ± 26 mL/min/1.73 m2, p < 0.001), with a ΔeGFRM0-M3 of 12 ± 19 mL/min/1.73 m2. The eGFR at 12 months was higher than at 3 months (44 ± 13 vs. 40 ± 24 mL/min/1.73 m2, p = 0.003). The factors significantly associated with the ΔeGFRM0-M3 in multivariate analysis were the percentage of cellular crescents and neurological involvement. The mean increase in the eGFR was 2.90 ± 0.06 mL/min/1.73 m2 for every 10-point gain in the percentage of cellular crescents. Conclusions: Early renal recovery after the first flare of pauci-immune glomerulonephritis occurred mainly in the first 3 months of treatment. The percentage of cellular crescents was the main independent predictor of early renal recovery.
MeSH term(s)	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis ; Antibodies, Antineutrophil Cytoplasmic ; Female ; Glomerulonephritis/diagnosis ; Humans ; Kidney ; Male ; Retrospective Studies
Chemical Substances	Antibodies, Antineutrophil Cytoplasmic
Language	English
Publishing date	2022-01-17
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	604540-6
ISSN	1421-9670 ; 0250-8095
ISSN (online)	1421-9670
ISSN	0250-8095
DOI	10.1159/000520285
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1635: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.

Teissier, Thibault / Quersin, Valentine / Gnemmi, Viviane / Daroux, Maité / Howsam, Mike / Delguste, Florian / Lemoine, Cécile / Fradin, Chantal / Schmidt, Ann-Marie / Cauffiez, Christelle / Brousseau, Thierry / Glowacki, François / Tessier, Frédéric J / Boulanger, Eric / Frimat, Marie

Aging cell

2019 Volume 18, Issue 2, Page(s) e12850

Abstract: Pro-aging effects of endogenous advanced glycation end-products (AGEs) have been reported, and there is increasing interest in the pro-inflammatory and -fibrotic effects of their binding to RAGE (the main AGE receptor). The role of dietary AGEs in aging ... ...

Abstract	Pro-aging effects of endogenous advanced glycation end-products (AGEs) have been reported, and there is increasing interest in the pro-inflammatory and -fibrotic effects of their binding to RAGE (the main AGE receptor). The role of dietary AGEs in aging remains ill-defined, but the predominantly renal accumulation of dietary carboxymethyllysine (CML) suggests the kidneys may be particularly affected. We studied the impact of RAGE invalidation and a CML-enriched diet on renal aging. Two-month-old male, wild-type (WT) and RAGE
MeSH term(s)	Aging/metabolism ; Animals ; Kidney Diseases/metabolism ; Kidney Diseases/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Receptor for Advanced Glycation End Products/deficiency ; Receptor for Advanced Glycation End Products/metabolism
Chemical Substances	Ager protein, mouse ; Receptor for Advanced Glycation End Products
Language	English
Publishing date	2019-02-22
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2113083-8
ISSN	1474-9726 ; 1474-9718
ISSN (online)	1474-9726
ISSN	1474-9718
DOI	10.1111/acel.12850
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6581: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Spécificités des néphropathies du sujet âgé.

Hamroun, Aghilès / Frimat, Marie / Beuscart, Jean-Baptiste / Buob, David / Lionet, Arnaud / Lebas, Céline / Daroux, Maïté / Provôt, François / Hazzan, Marc / Boulanger, Éric / Glowacki, François

Nephrologie & therapeutique

2019 Volume 15, Issue 7, Page(s) 533–552

Abstract: In our aging population, kidney disease management needs to take into account the frailty of the elderly. Standardized geriatric assessments can be proposed to help clinicians apprehend this dimension in their daily practice. These tools allow to better ... ...

Title translation	Kidney disease care for the elderly.
Abstract	In our aging population, kidney disease management needs to take into account the frailty of the elderly. Standardized geriatric assessments can be proposed to help clinicians apprehend this dimension in their daily practice. These tools allow to better identify frail patients and offer them more personalized and harmless treatments. This article aims to focus on the kidney diseases commonly observed in elderly patients and analyze their specific nephrogeriatric care modalities. It should be noticed that all known kidney diseases can be also observed in the elderly, most often with a quite similar clinical presentation. This review is thus focused on the diseases most frequently and most specifically observed in elderly patients (except for monoclonal gammopathy associated nephropathies, out of the scope of this work), as well as the peculiarities of old age nephrological care.
MeSH term(s)	Age Distribution ; Age Factors ; Aged ; Aged, 80 and over ; Antihypertensive Agents/therapeutic use ; Biopsy ; Comorbidity ; Diabetic Nephropathies/diagnosis ; Diabetic Nephropathies/epidemiology ; Diabetic Nephropathies/therapy ; Disease Management ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Embolism, Cholesterol/epidemiology ; Female ; Frail Elderly ; Humans ; Hypertension/epidemiology ; Hypertension/etiology ; Hypoglycemic Agents/therapeutic use ; Hypolipidemic Agents/therapeutic use ; Kidney Diseases/classification ; Kidney Diseases/diagnosis ; Kidney Diseases/epidemiology ; Kidney Diseases/therapy ; Male ; Precision Medicine ; Randomized Controlled Trials as Topic ; Risk
Chemical Substances	Antihypertensive Agents ; Hypoglycemic Agents ; Hypolipidemic Agents
Language	French
Publishing date	2019-11-09
Publishing country	France
Document type	Journal Article ; Review
ZDB-ID	2229575-6
ISSN	1872-9177 ; 1769-7255
ISSN (online)	1872-9177
ISSN	1769-7255
DOI	10.1016/j.nephro.2019.10.001
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6298: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: A Nearly Packaging-Free Design Paradigm for Light, Powerful, and Energy-Dense Primary Microbatteries.

Yue, Xiujun / Johnson, Alissa C / Kim, Sungbong / Kohlmeyer, Ryan R / Patra, Arghya / Grzyb, Jessica / Padmanabha, Akaash / Wang, Min / Jiang, Zhimin / Sun, Pengcheng / Kiggins, Chadd T / Ates, Mehmet N / Singh, Sonika V / Beale, Evan M / Daroux, Mark / Blake, Aaron J / Cook, John B / Braun, Paul V / Pikul, James H

Advanced materials (Deerfield Beach, Fla.)

2021 Volume 33, Issue 35, Page(s) e2101760

Abstract: Billions of internet connected devices used for medicine, wearables, and robotics require microbattery power sources, but the conflicting scaling laws between electronics and energy storage have led to inadequate power sources that severely limit the ... ...

Abstract	Billions of internet connected devices used for medicine, wearables, and robotics require microbattery power sources, but the conflicting scaling laws between electronics and energy storage have led to inadequate power sources that severely limit the performance of these physically small devices. Reported here is a new design paradigm for primary microbatteries that drastically improves energy and power density by eliminating the vast majority of the packaging and through the use of high-energy-density anode and cathode materials. These light (50-80 mg) and small (20-40 µL) microbatteries are enabled though the electroplating of 130 µm-thick 94% dense additive-free and crystallographically oriented LiCoO
Language	English
Publishing date	2021-07-19
Publishing country	Germany
Document type	Journal Article
ZDB-ID	1474949-X
ISSN	1521-4095 ; 0935-9648
ISSN (online)	1521-4095
ISSN	0935-9648
DOI	10.1002/adma.202101760
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Details ▾
- Full text online
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito